You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Biomagnetic Sensor for Detecting Breast Cancer

    SBC: SENIOR SCIENTIFIC            Topic: N/A

    DESCRIPTION (provided by applicant): The principal objective of this application is to establish a new methodology for the early detection of abnormal lesions, whether pre-cancerous or cancerous, in breast imaging. Early detection is crucial to identifying lesions while they are still contained when the cure rate is near 100%. Existing mammography often does not identify lesions until significant ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  2. A BIOMAGNETIC SENSOR FOR DETECTING BREAST CANCER

    SBC: SENIOR SCIENTIFIC            Topic: N/A

    Early detection of breast cancer is a primary goal in cancer imaging and it is important to identify tumors at an early stage of growth to identify their type. Standard x-ray mammography does not always provide adequate diagnosis; e.g., in cases such as dense or radiation-scarred breasts, and often does not identify tumor presence until significant growth has occurred. Alternative methods are bei ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. A Broad, Long Acting Inhibitor of Botulinum Neurotoxin

    SBC: BIOREXIS PHARMACEUTICAL CORPORATION            Topic: N/A

    DESCRIPTION (provided by investigator): Rexis plans to develop a broad acting antitoxin to Clostridium botulinum Neurotoxin Serotypes A, B and E (possibly C, D, F and G) offering high stability, bio-distribution and extended protection due to long circul

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Accelerated x-ray therapy planning system PEREGRINE

    SBC: NOMOS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Computerized radiation therapy planning systems (RTP) are essential in Radiation Oncology for quantitative evaluation of radiation doses prior to patient treatment. Among currently available computational methods, the Monte Carlo method of calculating dose distributionsis most universal and accurate. It is believed that Monte Carlo software packages will become ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Accelerated x-ray therapy planning system PEREGRINE

    SBC: NOMOS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Computerized radiation therapy planning systems (RTP) are essential in Radiation Oncology for quantitative evaluation of radiation doses prior to patient treatment. Among currently available computational methods, the

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. A computer-based brief intervention for college drinkers

    SBC: BEHAVIOR THERAPY ASSOCIATES, LLP            Topic: N/A

    DESCRIPTION (provided by applicant): The goals of this project are to develop, evaluate, and disseminate two software programs that provide brief motivational interventions for heavy drinking college students: The College Drinker's Check-ups (CDCU

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. ACTIVE MIXING MEMBRANE OXYGENATOR PHASE II

    SBC: ENSION Inc            Topic: N/A

    Ension, Inc. and its development partner, the University of Pittsburgh, have developed and patented an active mixing membrane oxygenator (AMMO), which has been proven to be highly efficient in terms of oxygenation and decarbonation (5-8 times that of oxygenators currently in use), capable of pumping blood and atraumatic to blood. The AMMO achieves its efficiency by rotating flow-through discs of m ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. ACTIVE MIXING MEMBRANE OXYGENATOR PHASE II

    SBC: ENSION Inc            Topic: N/A

    Ension, Inc. and its development partner, the University of Pittsburgh, have developed and patented an active mixing membrane oxygenator (AMMO), which has been proven to be highly efficient in terms of oxygenation and decarbonation (5-8 times that of oxygenators currently in use), capable of pumping blood and atraumatic to blood. The AMMO achieves its efficiency by rotating flow-through discs of m ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  9. ADAPTIVE OPTICS FUNDUS IMAGER

    SBC: KESTREL CORP            Topic: N/A

    DESCRIPTION (provided by applicant): In Phase I Kestrel Corporation developed and demonstrated a retinal imaging system that combines multispectral imaging techniques with adaptive optics and image deconvolution to provide high resolution less than (

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. ADAPTIVE OPTICS FUNDUS IMAGER

    SBC: KESTREL CORP            Topic: N/A

    DESCRIPTION (provided by applicant): In Phase I Kestrel Corporation developed and demonstrated a retinal imaging system that combines multispectral imaging techniques with adaptive optics and image deconvolution to provide high resolution less than (

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government